--2025/Q1-- / 35.614M--
--2024/Q4-- / 40.912M--
Nov 7, 20242024/Q337.428M / 44.505M--
Aug 8, 20242024/Q243.648M / 43.653M--
May 9, 20242024/Q132.607M / 46.087M--
US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 1.7950
- -0.0050-0.28%
Trading Nov 19 13:32 ET
391.64MMarket Cap-8159P/E (TTM)
1.8200High1.7648Low677.23KVolume1.7900Open1.8000Pre Close1.22MTurnover0.34%Turnover RatioLossP/E (Static)218.18MShares2.480052wk High-7.77P/B355.90MFloat Cap0.800052wk Low--Dividend TTM198.27MShs Float31.0000Historical High--Div YieldTTM3.07%Amplitude0.2410Historical Low1.7950Avg Price1Lot Size
Akebia Therapeutics Key Stats
Akebia Therapeutics Q3 2024 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 44.51M | 37.43M | -7.08M |
| Miss Est. | +5.85% | -10.98% | -15.90% |
| EPS | -0.06 | -0.10 | -0.04 |
| Miss Est. | +20.90% | -25.00% | -58.23% |
Analyst Rating
Nov 14, 2024
Akebia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Akebia Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data